Evidence map›Paper›PMID 36615306›Full record

ArticleMolecules (Basel, Switzerland)2022

Cannabidiol as Self-Assembly Inducer for Anticancer Drug-Based Nanoparticles.

Eleonora Colombo, Davide Andrea Coppini, Laura Polito, Umberto Ciriello, Giuseppe Paladino, Mariafrancesca Hyeraci, Maria Luisa Di Paolo, Giulia Nordio, Lisa Dalla Via, Daniele Passarella

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Eleonora ColomboDepartment of Chemistry, Università degli Studi di Milano, 20133 Milan, Italy.
Davide Andrea CoppiniDepartment of Chemistry, Università degli Studi di Milano, 20133 Milan, Italy.ORCID 0000-0003-3688-8235
Laura PolitoIstituto di Scienze e Tecnologie Chimiche (SCITEC) "Giulio Natta", Consiglio Nazionale delle Ricerche (CNR), 20138 Milan, Italy.ORCID 0000-0002-7756-2365
Umberto CirielloLINNEA SA, 6595 Riazzino, Switzerland.
Giuseppe PaladinoLINNEA SA, 6595 Riazzino, Switzerland.
Mariafrancesca HyeraciDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy.ORCID 0000-0001-9376-5974
Maria Luisa Di PaoloDepartment of Molecular Medicine, University of Padova, 35131 Padova, Italy.ORCID 0000-0002-2370-9333
Giulia NordioDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy.
Lisa Dalla ViaDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy.ORCID 0000-0002-9828-9388
Daniele PassarellaDepartment of Chemistry, Università degli Studi di Milano, 20133 Milan, Italy.ORCID 0000-0001-6180-9581
University of Padua · ITUniversity of Milan · ITBrigham and Women's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cannabidiol (CBD) is a biologically active compound present in the plants of the

Indexed as

Antineoplastic AgentsCannabidiolNanoparticlesCell Line, TumorHumansPaclitaxelAntineoplastic AgentsCannabidiolPaclitaxelanticancer drugcannabidiolself-assembled nanoparticles

Identifiers

PMID36615306
PMCPMC9822096
OpenAlexW4312171773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.